Dr. Sina Aboutalebi, MD

Dr. Aboutalebi practices at Abilene Dermatology And Skin Surgery Center in Abilene, Texas.

Dr. Aboutalebi's NPI, 1932391232, was assigned on August 10, 2007. Dr. Aboutalebi graduated from Texas Tech University Health Sciences Center School of Medicine in 2005. Dr. Aboutalebi holds Texas license N0588.

Dr. Aboutalebi's primary practice is Abilene Dermatology and Skin Surgery Center, at 3190 Antilley Rd, Abilene, TX 79606-5006. The practice phone is (325) 672-9211.

Dr. Aboutalebi's primary practice is Abilene Dermatology And Skin Surgery Center in Abilene, Texas. Dr. Aboutalebi is also affiliated with Hendrick Medical Center. The medical group on file is Abilene Dermatology & Skin Surgery Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aboutalebi practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Aboutalebi's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Aboutalebi is board certified in dermatology by the American Board of Dermatology. Dr. Aboutalebi is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and minor head injury among the conditions Dr. Aboutalebi treats.

CMS data shows 12,148 Medicare services from Dr. Aboutalebi across 41 procedure codes in 2024, for 1,917 Medicare patients. Medicare paid $1,467,354 for them. Every service was in an office.

CMS counts 1,917 Medicare patients who saw Dr. Aboutalebi in 2024. The largest group is 65 to 74, with 912 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Aboutalebi's median patient age at 76, with 40% women.

In 2024, Dr. Aboutalebi wrote 2,170 Medicare Part D claims for 884 patients. 94% of them were for generic drugs. CMS names the drug for 2,040 of them, across 22 drugs with 11 or more claims each, at $697,375 in total drug cost. In 2023, CMS named 1,790 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Aboutalebi for performance year 2024, reported individually. Dr. Aboutalebi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,418 procedures of removal of skin lesions by Dr. Aboutalebi, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Aboutalebi, published from 2021 to 2024. The most frequent topics are Skin Neoplasms. Dr. Aboutalebi has published most often in Cutis. Dr. Aboutalebi's most frequent co-authors are Cloyce L. Stetson, MD, Michelle Babb Tarbox, MD and Jay Michael Truitt, MD, MPH, PharmD, PhD.

CMS Open Payments shows 977 general payments to Dr. Aboutalebi from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $4,904.

Dr. Aboutalebi graduated from Texas Tech University Health Sciences Center School of Medicine in 2005.

Dr. Aboutalebi is in network with 20 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.